無料プレビュー

Novartis AG (NVS) · New York Stock Exchange

プロフィール

Novartis AG is an innovative medicines company engaged in research, development, manufacturing, distribution, marketing and sale of pharmaceutical products across cardiovascular, renal and metabolic; immunology; neuroscience; and oncology therapeutic areas. Key marketed products include Entresto for heart failure, Cosentyx for immunological diseases, Kisqali for breast cancer, Kesimpta for multiple sclerosis, and Pluvicto for prostate cancer, among others. The company operates through five organizational units: Biomedical Research, Development, Operations, and two commercial units (US and Inte

主要指標

株価: $143.11 (-0.12%)
時価総額: 2,720億ドル
PER（今期予想）: 16.2
PBR: 6.6
配当利回り: 3.31%
52週レンジ: $121.57 – $170.46
業種: Healthcare / Drug Manufacturers - General
上場: New York Stock Exchange
構成銘柄: —

比較会社: LLY Eli Lilly and Company、JNJ Johnson & Johnson、ABBV AbbVie Inc.、MRK Merck & Co., Inc.、AZN AstraZeneca PLC、AMGN Amgen Inc.、GILD Gilead Sciences, Inc.、NVO Novo Nordisk A/S

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-10-27 · 更新: 2026-10-09